33 related articles for article (PubMed ID: 1316919)
1. Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes.
Karima MM; Van Dyke TE
J Periodontol; 2012 Jun; 83(6):780-6. PubMed ID: 22050547
[TBL] [Abstract][Full Text] [Related]
2. Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.
Eckels PC; Banerjee A; Moore EE; McLaughlin NJ; Gries LM; Kelher MR; England KM; Gamboni-Robertson F; Khan SY; Silliman CC
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C886-97. PubMed ID: 19295175
[TBL] [Abstract][Full Text] [Related]
3. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
Chaithra VH; Jacob SP; Lakshmikanth CL; Sumanth MS; Abhilasha KV; Chen CH; Thyagarajan A; Sahu RP; Travers JB; McIntyre TM; Kemparaju K; Marathe GK
J Lipid Res; 2018 Nov; 59(11):2063-2074. PubMed ID: 30139761
[TBL] [Abstract][Full Text] [Related]
4. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages.
Beck-Speier I; Dayal N; Karg E; Maier KL; Roth C; Ziesenis A; Heyder J
Environ Health Perspect; 2001 Aug; 109 Suppl 4(Suppl 4):613-8. PubMed ID: 11544173
[TBL] [Abstract][Full Text] [Related]
5. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase.
Kuijpers TW; van den Berg JM; Tool AT; Roos D
Clin Exp Immunol; 2001 Mar; 123(3):412-20. PubMed ID: 11298128
[TBL] [Abstract][Full Text] [Related]
6. Structural and (patho)physiological diversity of PAF.
Pinckard RN; Woodard DS; Showell HJ; Conklyn MJ; Novak MJ; McManus LM
Clin Rev Allergy; 1994; 12(4):329-59. PubMed ID: 7743461
[No Abstract] [Full Text] [Related]
7. Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling.
Marathe GK; Chaithra VH; Ke LY; Chen CH
Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106478. PubMed ID: 32711129
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.
Snyder F
Am J Physiol; 1990 Nov; 259(5 Pt 1):C697-708. PubMed ID: 2240190
[TBL] [Abstract][Full Text] [Related]
9. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
[TBL] [Abstract][Full Text] [Related]
10. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production.
Pinckard RN; Prihoda TJ
J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994
[TBL] [Abstract][Full Text] [Related]
11. Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium.
Walker BA; Hagenlocker BE; Ward PA
J Immunol; 1991 May; 146(9):3124-31. PubMed ID: 1849943
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
14. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
